[¹¹⁵I]YP20: A novel radioligand specific for the extracellular domain of the CRF₁ receptorGORDON, John C; EDWARDS, Phil; ELMORE, Charles S et al.European journal of pharmacology. 2010, Vol 649, Num 1-3, pp 59-63, issn 0014-2999, 5 p.Article

Conformational states of the corticotropin releasing factor 1 (CRF₁) receptor: detection, and pharmacological evaluation by peptide ligandsHOARE, Sam R. J; SULLIVAN, Susan K; PAHUJA, Anil et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 12, pp 1881-1897, issn 0196-9781, 17 p.Article

An arginine vasopressin V_1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy modelIIJIMA, Michihiko; CHAKI, Shigeyuki.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 3, pp 622-627, issn 0278-5846, 6 p.Article

Can CRF₁ receptor antagonists become antidepressant and/or anxiolytic agents?OVERSTREET, David H; KNAPP, Darin J; BREESE, George R et al.Drug development research. 2005, Vol 65, Num 4, pp 191-204, issn 0272-4391, 14 p.Article

Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptorsYOUHUA XU; RONGJIAN ZHANG; YUANYUAN GUO et al.British journal of pharmacology. 2009, Vol 157, Num 8, pp 1368-1379, issn 0007-1188, 12 p.Article

The role of CRF₁ receptors for sympathetic nervous response to laparotomy in anesthetized ratsUETSUKI, Nobuo; SEGAWA, Hajime; MAYAHARA, Taku et al.Brain research. 2005, Vol 1044, Num 1, pp 107-115, issn 0006-8993, 9 p.Article

CORTICOTROPIN RELEASING FACTOR-1 RECEPTOR ANTAGONIST, CP-154,526, BLOCKS THE EXPRESSION OF ETHANOL-INDUCED BEHAVIORAL SENSITIZATION IN DBA/2J MICEFEE, J. R; SPARTA, D. R; PICKER, M. J et al.Neuroscience. 2007, Vol 150, Num 1, pp 14-21, issn 0306-4522, 8 p.Article

Blockade of the Corticotropin Releasing Factor Type 1 Receptor Attenuates Elevated Ethanol Drinking Associated With Drinking in the Dark ProceduresSPARTA, Dennis R; SPARROW, Angela M; LOWERY, Emily G et al.Alcoholism, clinical and experimental research. 2008, Vol 32, Num 2, pp 259-265, issn 0145-6008, 7 p.Article

Development of CRF₁ receptor antagonists as antidepressants and anxiolytics: Progress to dateVALDEZ, Glenn R.CNS drugs. 2006, Vol 20, Num 11, pp 887-896, issn 1172-7047, 10 p.Article

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF₁ receptorGEHLERT, Donald R; SHEKHAR, Anantha; MORIN, S. Michelle et al.European journal of pharmacology. 2005, Vol 509, Num 2-3, pp 145-153, issn 0014-2999, 9 p.Article

High-affinity CRF₁ receptor antagonist NBI-34041 : Preclinical and clinical data suggest safety and efficacy in attenuating elevated stress responseISING, Marcus; ZIMMERMANN, Ulrich S; KÜNZE, Heike E et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 9, pp 1941-1949, issn 0893-133X, 9 p.Article

The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in miceURANI, Alexandre; PHILBERT, Julie; COHEN, Caroline et al.Pharmacology, biochemistry and behavior. 2011, Vol 98, Num 3, pp 425-431, issn 0091-3057, 7 p.Article

Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF1) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonismDAUTZENBERG, Frank M; WILLE, Sandra.Regulatory peptides. 2004, Vol 118, Num 3, pp 165-173, issn 0167-0115, 9 p.Article

Effect of long-term blockade of CRF₁ receptors on exploratory behaviour, monoamines and transcription factor AP-2MÄLLO, Tanel; BERGGARD, Cecilia; ELLER, Marika et al.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 4, pp 855-865, issn 0091-3057, 11 p.Article

Control by tachykinin NK₂ receptors of CRF₁ receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pigDESVIGNES, C; ROUQUIER, L; SOUILHAC, J et al.Neuropeptides (Edinburgh). 2003, Vol 37, Num 2, pp 89-97, issn 0143-4179, 9 p.Article

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH₁ Antagonist) in the Treatment of Major DepressionBINNEMAN, Brendon; FELTNER, Douglas; KOLLURI, Sheela et al.The American journal of psychiatry. 2008, Vol 165, Num 5, pp 617-620, issn 0002-953X, 4 p.Article

Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF₁ receptorsZORRILLA, Eric P; SCHULTEIS, Gery; ORMSBY, Amanda et al.Brain research. 2002, Vol 952, Num 2, pp 200-210, issn 0006-8993Article

Preliminary evidence of anxiolytic effects of the CRF₁ receptor antagonist R317573 in the 7.5% CO₂ proof-of-concept experimental model of human anxietyBAILEY, Jayne E; PAPADOPOULOS, Andreas; DIAPER, Alison et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 9, pp 1199-1206, issn 0269-8811, 8 p.Article

Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF₁ receptor antagonistsHUANG, Charles Q; WILCOXEN, Keith M; GRIGORIADIS, Dimitri E et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 15, pp 3943-3947, issn 0960-894X, 5 p.Article

Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptorWEBB, Thomas R; MORAN, Terry; HUANG, Charles Q et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 15, pp 3869-3873, issn 0960-894X, 5 p.Article

A novel water-soluble selective CRF₁ receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in ratsMILLION, Mulugeta; GRIGORIADIS, Dimitri E; SULLIVAN, Sue et al.Brain research. 2003, Vol 985, Num 1, pp 32-42, issn 0006-8993, 11 p.Article

The CRF₁ receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded ratsLODGE, D. J; LAWRENCE, A. J.Neuroscience. 2003, Vol 117, Num 2, pp 243-247, issn 0306-4522, 5 p.Article

The effect of chronic CRF₁ receptor blockade on the central CCK systems of Fawn-Hooded ratsLODGE, Daniel J; LAWRENCE, Andrew J.Regulatory peptides. 2003, Vol 116, Num 1-3, pp 27-33, issn 0167-0115, 7 p.Article

The CRF₁ receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in ratsMARINELLI, Peter W; FUNK, Douglas; JUZYTSCH, Walter et al.Psychopharmacologia. 2007, Vol 195, Num 3, pp 345-355, issn 0033-3158, 11 p.Article

Dissociation between opioid and CRF₁ antagonist sensitive drinking in Sardinian alcohol-preferring ratsSABINO, Valentina; COTTONE, Pietro; KOOB, George F et al.Psychopharmacologia. 2006, Vol 189, Num 2, pp 175-186, issn 0033-3158, 12 p.Article